CTOs on the Move


 
Avanos is a medical device company focused on delivering clinically superior breakthrough solutions that will help patients get back to the things that matter. Headquartered in Alpharetta, Georgia, Avanos is committed to creating the next generation of innovative healthcare solutions which will address our most important healthcare needs, such as reducing the use of opioids while helping patients move from surgery to recovery. Avanos develops, manufactures and markets its recognized brands in more than 90 countries.
  • Number of Employees: 1K-5K
  • Annual Revenue: $500M-1 Billion
  • www.avanos.com
  • 5405 Windward Parkway
    Alpharetta, GA USA 30004
  • Phone: 844.428.2667

Executives

Name Title Contact Details
Sudheer Paduchuri
Director, IT Infrastructure, Security and Operations Profile
Michael Greiner
Senior Vice President and Chief Financial Officer Profile
Siobhan Smyth
Chief Information Officer Profile
Paul Telle
Associate Director, Cybersecurity Architecture Profile

Similar Companies

UT Technology

UT Technology Inc. is a Edmonton, AB-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

QuickMedical - Medical Equipment and SUpplies

QuickMedical - Medical Equipment and SUpplies is a Issaquah, WA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Becon Medical

Becon Medical is a Tucson, AZ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

West Side Resources

West Side Resources is a Irvine, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

MY01

MY01 is a state-of-the-art medical device geared towards aiding in the detection of Compartment Syndrome (CS); a limb-threatening muscle condition that occurs within 48 hours following trauma. Currently, ACS is diagnosed based on subjective and unreliable outcomes like pain (known as 6 P`s), which when present cannot confirm the diagnosis in time for effective intervention. This leads to increased complications (muscle necrosis/amputation) and costs the US healthcare system more than $2.25 B annually. MY01 is capitalizing on a proven correlation between sustained increase in Intramuscular pressures and ACS for objective, early diagnosis. MY01 operationalizes muscular pressure monitoring into a simple, accurate single-use device. MY01. The simple solution to a dangerous problem.